Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (nâ¯=â¯4532).

Brookman-May, Sabine D; May, Matthias

Re: Androgen-deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-based Study (nâ¯=â¯4532).

Brookman-May, Sabine D; May, Matthias.

Brookman-May SD; Janssen Research and Development Oncology, Los Angeles, CA, USA; Janssen Pharma Research and Development Oncology, Los Angeles, CA, USA. Electronic address: sabine.brookman-may@email.de.
May M; Department of Urology, St. Elisabeth-Hospital, Straubing, Germany.

Eur Urol ; 78(6): 930-931, 2020 12.

Article in English | MEDLINE | ID: covidwho-599594

Subject(s)

COVID-19; Prostatic Neoplasms; Androgen Antagonists/adverse effects; Androgens; Humans; Male; Pandemics; Population; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/epidemiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prostatic Neoplasms / COVID-19 Type of study: Observational study / Prognostic study Limits: Humans / Male Language: English Journal: Eur Urol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google